From Pfizer to the FDA and then back to Pfizer — doin' the Washington Waltz

And I’ll be at raytheon — we’ll make beautiful music together

Former Top Drug Regulator Lands Cushy Pfizer Gig After Leaving FDA During Trump Transition

Patrizia Cavazzoni, the former director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, will serve as Pfizer’s Chief Medical Officer, the company announced Monday.

Cavazzoni retired from the FDA shortly before President Trump took office in January. She now rejoins Pfizer after a previous nearly eight-year stint at the company to work in the very industry she was in charge of regulating.

In her new role, Cavazzoni will “lead Pfizer’s regulatory, pharmacovigilance, safety, epidemiology, and medical information and evidence generation, among other medical functions,” the company announced in a press release.

“Here is how it works. FDA rubber stamps Pfizer drugs & vaccines even when the evidence is poor FDA even pushes these products on children,” Dr. Vinay Prasad of the University of California-San Francisco wrote on X.

“Then, you leave FDA and get paid by Pfizer,” he continued. “This is corruption.”